Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesper B Andersen

Showing results (121-130 of 149) with videos related to

Pageof 15
Sort By:
Nature Reviews. Gastroenterology & Hepatology|April 21, 2016
Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)Jesus M Banales, Vincenzo Cardinale, Guido Carpino, et al.
Gut|June 10, 2024
PARP-1 selectively impairs <i>KRAS</i>-driven phenotypic and molecular features in intrahepatic cholangiocarcinomaFriederike L Keggenhoff, Darko Castven, Diana Becker, et al.
JHEP Reports : Innovation in Hepatology|October 21, 2024
Altered fatty acid metabolism rewires cholangiocarcinoma stemness featuresGiulia Lori, Mirella Pastore, Nadia Navari, et al.
Hepatology Communications|February 8, 2022
miR-579-3p Controls Hepatocellular Carcinoma Formation by Regulating the Phosphoinositide 3-Kinase-Protein Kinase B Pathway in Chronically Inflamed LiverCristina Quintavalle, Nathalie Meyer-Schaller, Stephanie Roessler, et al.
Gut|September 10, 2020
TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanismsAitor Esparza-Baquer, Ibone Labiano, Omar Sharif, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 27, 2024
Ganglioside GD2 Contributes to a Stem-Like Phenotype in Intrahepatic CholangiocarcinomaAntonella Mannini, Mirella Pastore, Alessia Giachi, et al.
Journal of Hepatology|February 27, 2017
SOX17 regulates cholangiocyte differentiation and acts as a tumor suppressor in cholangiocarcinomaMaite Merino-Azpitarte, Elisa Lozano, María J Perugorria, et al.
Journal of Hepatology|February 26, 2022
Targeting NAE1-mediated protein hyper-NEDDylation halts cholangiocarcinogenesis and impacts on tumor-stroma crosstalk in experimental modelsPaula Olaizola, Pui Yuen Lee-Law, Maite G Fernandez-Barrena, et al.
Signal Transduction and Targeted Therapy|April 28, 2026
MARCO promotes cholangiocarcinogenesis by inducing immunosuppression and its targeting reduces tumor growthAloña Agirre-Lizaso, Maider Huici-Izagirre, Colm J O'Rourke, et al.
Journal of Gastrointestinal Oncology|January 13, 2017
Advances in cholangiocarcinoma research: report from the third Cholangiocarcinoma Foundation Annual ConferenceGhassan K Abou-Alfa, Jesper B Andersen, William Chapman, et al.
Pageof 15

Showing results (121-130 of 149) with videos related to

Sort By:
Pageof 15
Nature Reviews. Gastroenterology & Hepatology|April 21, 2016
Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)Jesus M Banales, Vincenzo Cardinale, Guido Carpino, et al.
Gut|June 10, 2024
PARP-1 selectively impairs <i>KRAS</i>-driven phenotypic and molecular features in intrahepatic cholangiocarcinomaFriederike L Keggenhoff, Darko Castven, Diana Becker, et al.
JHEP Reports : Innovation in Hepatology|October 21, 2024
Altered fatty acid metabolism rewires cholangiocarcinoma stemness featuresGiulia Lori, Mirella Pastore, Nadia Navari, et al.
Hepatology Communications|February 8, 2022
miR-579-3p Controls Hepatocellular Carcinoma Formation by Regulating the Phosphoinositide 3-Kinase-Protein Kinase B Pathway in Chronically Inflamed LiverCristina Quintavalle, Nathalie Meyer-Schaller, Stephanie Roessler, et al.
Gut|September 10, 2020
TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanismsAitor Esparza-Baquer, Ibone Labiano, Omar Sharif, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 27, 2024
Ganglioside GD2 Contributes to a Stem-Like Phenotype in Intrahepatic CholangiocarcinomaAntonella Mannini, Mirella Pastore, Alessia Giachi, et al.
Journal of Hepatology|February 27, 2017
SOX17 regulates cholangiocyte differentiation and acts as a tumor suppressor in cholangiocarcinomaMaite Merino-Azpitarte, Elisa Lozano, María J Perugorria, et al.
Journal of Hepatology|February 26, 2022
Targeting NAE1-mediated protein hyper-NEDDylation halts cholangiocarcinogenesis and impacts on tumor-stroma crosstalk in experimental modelsPaula Olaizola, Pui Yuen Lee-Law, Maite G Fernandez-Barrena, et al.
Signal Transduction and Targeted Therapy|April 28, 2026
MARCO promotes cholangiocarcinogenesis by inducing immunosuppression and its targeting reduces tumor growthAloña Agirre-Lizaso, Maider Huici-Izagirre, Colm J O'Rourke, et al.
Journal of Gastrointestinal Oncology|January 13, 2017
Advances in cholangiocarcinoma research: report from the third Cholangiocarcinoma Foundation Annual ConferenceGhassan K Abou-Alfa, Jesper B Andersen, William Chapman, et al.
Pageof 15